微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 37.55% | 26.19% | 16.52% | 96/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 32.23% | 24.24% | 3.4% | 107/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 31.17% | 20.14% | 2.92% | 109/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 30.29% | 11.51% | 1.76% | 111/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 29.76% | 8.2% | 14.73% | 110/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 25.94% | -17.71% | -0.01% | 117/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 25.94% | -15.98% | -4.48% | 113/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 27.16% | -19.79% | -1.26% | 115/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 27.51% | -20.79% | -12.74% | 110/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 31.52% | -12.56% | 2.09% | 111/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 30.88% | -17.6% | -8.8% | 106/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 33.86% | -9.33% | -2.5% | 106/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 34.72% | -3.49% | -3.67% | 100/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 36.05% | -9.15% | -3.79% | 106/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 37.47% | -3.28% | 0.34% | 97/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 37.34% | -3.35% | 3.79% | 101/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 35.98% | -9.04% | -9.32% | 92/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 39.68% | 17% | 2.43% | 106/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 38.74% | 14.63% | 0.27% | 92/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 38.64% | 20.99% | -2.33% | 98/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 39.56% | 13.19% | 16.64% | 82/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 33.91% | 10.28% | 0.35% | 113/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 33.79% | 13.85% | 5.83% | 82/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 31.93% | 9.27% | -8.62% | 102/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 34.95% | 12.72% | 13.64% | 67/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 30.75% | -6.34% | 3.59% | 104/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 29.68% | -12.92% | 1.58% | 58/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 29.22% | -16.84% | -5.74% | 68/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 31% | -11.26% | -5.57% | 48/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 32.83% | -14.48% | -3.69% | 96/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 34.09% | -20.55% | -3% | 41/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 35.14% | -20.91% | 0.59% | 45/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 34.94% | -21.28% | -8.99% | 39/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 38.39% | -14.17% | -10.53% | 78/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 42.91% | -5.01% | -3.44% | 30/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 44.43% | -0.85% | 0.12% | 36/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 44.38% | -2.41% | -0.77% | 28/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 44.73% | 2.73% | -0.98% | 53/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 45.17% | 8.66% | 0.8% | 23/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 44.82% | 8.2% | -1.46% | 28/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 45.48% | 6.39% | 4.45% | 17/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |